Max Robotics — Global Service Robot Directory + US Certification

About

Cheol Kwak is a leading urologic surgeon whose research has fundamentally advanced the surgical management of prostate and kidney cancers, particularly through the adoption and refinement of robotic-assisted techniques. His work is distinguished by rigorous comparative effectiveness studies that have shaped clinical decision-making. Kwak’s landmark multicenter matched-pair comparison demonstrated superior perioperative and long-term renal functional outcomes for robotic versus laparoscopic partial nephrectomy (43 citations), establishing a key evidence base for robotic nephron-sparing surgery. He has also been at the forefront of improving functional outcomes after radical prostatectomy, notably through a first-in-human feasibility study that developed a novel intraoperative monitoring and mapping method for the cavernous nerve (23 citations), a critical step toward preserving erectile function. His comprehensive analyses have clarified the impact of prostate volume on oncological and functional outcomes (27 citations) and the predictors and implications of positive surgical margins (24 and 13 citations). Furthermore, Kwak’s multi-institutional study in Korea provided essential data on the clinical outcomes and cost-effectiveness of robotic surgery (20 citations), influencing healthcare policy. Through his pioneering work on nerve-sparing techniques and innovative surgical methods like the sliding loop for renorrhaphy, Cheol Kwak has significantly enhanced the precision and safety of urologic oncology surgery.